Insomnia
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Insomnia volunteers were included in the criteria 2. In line with the diagnostic criteria for chronic insomnia and deficiency of the heart and spleen, difficulty in sleeping and awakening cannot be better explained by other types of sleep disorders, and the following seven conditions are met: A. It meets the diagnostic criteria of insomnia disorder and primary insomnia with deficiency of heart and spleen; B. Aged 50-55 years; C. Did not participate in other clinical researchers; D. Signed the informed consent form and volunteered to participate in the study; E. PSQI > 7 points, AIS > 6 points, SDS and SAS = 3 times/week can only be included in this study.
Exclusion criteria
Exclusion criteria: If a subject meets any of the following conditions, he/she will not be allowed to participate in the study. 1. Insomnia patients caused by excessive anxiety and depression; 2. Respiratory related sleep disorders, circadian rhythm sleep disorders and sleep disorders; 3. Insomnia patients suffering from systemic diseases such as pain, fever, cough, etc.; 4. Patients with cardiovascular, lung, liver, kidney, hematopoietic system and other serious primary diseases; 5. Patients with mental illness; 6. The skin at the treatment site is infected or hypersensitive; 7. Patients with progressive malignant tumors or other serious wasting diseases, which are prone to co-infection and bleeding; 8. Patients who have poor compliance, or fail to receive treatment as required; 9. For some reason, it is impossible to judge the curative effect or incomplete data affects the curative effect and judgement; 10. As a result of drug abuse or drug treatment, caused by insomnia patients; 11. Sleep disorders caused by long-term excessive drinking of alcohol, coffee, strong tea, etc., and adverse life factors; 12. A pregnant, menstruating, or lactating woman.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Corticotropin-releasing hormone;Adreno-cortico-tropic-hormone;Cortisol;Serotonin;?-aminobutyric acid;Norepinephrine;Prostaglandin 2;1HNMR;Resting state functional magnetic resonance imaging of the brain;Electrocardiogram;Electroencephalogram;PSQI;SAS;SDS; | — |
Secondary
| Measure | Time frame |
|---|---|
| Routine urine; | — |
Countries
China
Contacts
Department of Acupuncture and Moxibustion, Changchun University of Chinese Medicine